Breaking News

Cobra Biologics Pact Aims to Streamline Biologics Production

BBSRC competition invests £20M to bring innovative biotechnology projects to market

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cobra Biologics and The University of Manchester have been awarded collaborative funding of £217,000 as one of 23 projects that will share £20 million from the Innovate UK / Biotechnology and Biological Sciences Research Council (BBSRC). The joint project, PeriTune, will work to develop a protein expression optimization platform for the robust production of biologics. This platform aims to address key bottlenecks and manufacturability challenges of recombinant proteins used in both biopharma me...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters